Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
The funding bodies had no role in the writing of this review
Think of it like this: CJC 1295 is a Growth Hormone Releasing Hormone (GHRH) analogue
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
The team made three simultaneous changes to the GLP-1 backbone: a position-8 amino acid substitution to block DPP-4 cleavage, an arginine substitution to prevent fatty-chain attachment at the wrong lysine, and attachment of a C18 fatty diacid chain via a short PEG linker at lysine-26
US$ 21.21
US$ 24.53
US$ 25.47
